AstraZeneca
An experienced Associate Director leads the end-to-end design, development, and scale-up of Lentiviral Vector manufacturing processes for clinical and commercial scales. This strategic role focuses on suspension bioreactor platforms, driving process optimization from research through late-stage readiness within a collaborative, matrixed environment.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
19% above the average for this role
Senior Scientist, Viral Vector Process Development, Upstream
American Association of Physicists in Medicine
Exec Director, Viral Vector Process Development
Gilead Sciences
Upstream Principal Scientist, Vector Biology
Legend Biotech
Scientist - Upstream Technologies
Cepheid
Scientist I/II, Viral Vector Process Development
Asimov
Scientist/Senior Scientist, Viral Vector Analytical Development
Obsidian Therapeutics